Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 3, 2017
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trialsL Guenther, R B Warren, J C Cather, et al.The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.The British Journal of Dermatology|January 11, 2013
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-upK A Papp, C E M Griffiths, K Gordon, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2018
Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foamA Jalili, M Lebwohl, L Stein Gold, et al.Journal of the American Academy of Dermatology|February 25, 2000
Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasisA Gottlieb, J G Krueger, R Bright, et al.Archives of Dermatology|June 2, 1998
Consensus workshop on the toxic effects of long-term PUVA therapyW L Morison, R D Baughman, R M Day, et al.Journal of the American Academy of Dermatology|May 20, 1998
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasisM Lebwohl, E Ast, J P Callen, et al.Journal of the American Academy of Dermatology|June 12, 1999
Finasteride in the treatment of men with frontal male pattern hair lossJ Leyden, F Dunlap, B Miller, et al.Journal of the American Academy of Dermatology|July 25, 2000
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?G G Krueger, S R Feldman, C Camisa, et al.Journal of Molecular Medicine (Berlin, Germany)|April 12, 2000
A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structureL Cai, B Struk, M D Adams, et al.Pageof 12